MOMENTUM III: HeartMate III demonstrated 2-year Survival Benefit Compared to HeartMate II

Dr. Mehra and Dr. Gibson Discuss

Subscribe on iTunes or Google Play.

Podcast: Download

MOMENTUM III: HeartMate III demonstrated 2-year Survival Benefit Compared to HeartMate II Dr. Mehra and Dr. Gibson Discuss

CANTOS subanalysis: Effect of Canakinumab on New Onset Diabetes in Pre-Diabetic Patients

Dr. Everett and Dr. Gibson Discuss

Subscribe on iTunes or Google Play.

Podcast: Download

CANTOS subanalysis: Effect of Canakinumab on New Onset Diabetes in Pre-Diabetic Patients Dr. Everett and Dr. Gibson Discuss

ACC 2018 – Wrap Up in German

Dr. Silber Presents

Subscribe on iTunes or Google Play.

Podcast: Download

ACC 2018 – Wrap Up in German Dr. Silber Presents

TREAT: Ticagrelor vs. Clopidogrel After Thrombolytic Therapy in STEMI Patients

Dr. Berwanger and Dr. Daaboul Discuss

Subscribe on iTunes or Google Play.

Podcast: Download

TREAT: Ticagrelor vs. Clopidogrel After Thrombolytic Therapy in STEMI Patients Dr. Berwanger and Dr. Daaboul Discuss

Andexanet alfa: Rapid reversal of Factor Xa inhibitors

On Monday, March 12^th at ACC 2018 in Orlando, Florida, an interim analysis from the ongoing ANNEXA-4 study demonstrated that the first- in-class reversal drug for direct and indirect factor Xa inhibitors, Andexanet alfa, was able to effectively reverse the anti-factor Xa activity and control major bleeding events among patients taking one of four Factor Xa inhibitors (apixaban, rivaroxaban, edoxaban or enoxaparin). Continue reading →